Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
81 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

RKDA — Arcadia Biosciences, Inc. Dilution Risk Tracker

Track RKDA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RKDA — Get alerts when the score changes →

As of August 28, 2026, Arcadia Biosciences, Inc. (RKDA) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Arcadia Biosciences, Inc. has a market capitalization of $1.98M, 2.41M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $3.94M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
85
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 227% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 53%
• Low cash runway: 5 months remaining
• Active ATM program with $4M remaining capacity
🔄 Reverse Split model est. 45%
• 50-day avg $1.20 approaching $1 threshold
• Only 5 months cash — financial pressure
🔔 Track RKDA — Get forecast alerts →

Market Data

Market Cap$1.98M
Shares Outstanding2.41M
Float2.05M
Cash$4.18M
DebtN/A
Short InterestN/A

Institutional Holdings

1 institutional holders · 1 shares
#1 HARBOUR INVESTMENTS, INC. 1 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.5K
Days to Cover1.0
% of Float0.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2015-12-31
424B3 ATM 2026-02-11
EFFECT EFFECT 2026-02-10
S-3 SHELF 2026-01-28
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RKDA Dilution Snapshot

Arcadia Biosciences, Inc. (RKDA) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RKDA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RKDA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for RKDA
RKDA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.